Home » Topics » BioWorld

BioWorld
RSS

CANADA APPROVES GYNEX DRUG CHARGES

Jan. 16, 1992

SANDOZ TENDER OFFER WAITING PERIOD EXPIRES

Jan. 16, 1992

CANADA APPROVE IMMUNOMEDICS TRIALS

Jan. 15, 1992

ROBERTS TO BUY TRIALS MANAGEMENT COMPANY

Jan. 15, 1992

CYTRX FILES IND FOR BURN TREATMENT

Jan. 15, 1992

ONCOSCINT APPROVED IN ITALY

Jan. 15, 1992

ELAN AGREES TO ACQUIRE VEGA

Jan. 15, 1992

ALPHA-BETA BEGINS FIRST TRIALS

Jan. 15, 1992

ENZO STOCK CONTINUES TO RISE

Jan. 15, 1992

ZYNAXIS FILES FOR 2 MILLION-SHARE IP0

Jan. 15, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...